Table 7.
Association between PFS range, PERCIST response, and final restaging data.
| PFS <12 Months | PFS 12–24 Months | PFS >24 Months | ||
|---|---|---|---|---|
| PERCIST response | NA | 40.0% | 25.0% | 64.3% |
| CMR | 0.0% | 37.5% | 28.6% | |
| SMD | 0.0% | 25.0% | 0.0% | |
| PMR | 0.0% | 0.0% | 7.1% | |
| PMD | 60% | 12.5% | 0.0% | |
| Final restaging | Excellent response | 25% | 9.1% | 35.3% |
| Biochemical persistence | 25% | 45.5% | 52.9% | |
| Structural persistence | 50% | 45.5% | 11.8% | |
NA: not available; CMR: complete metabolic response; SMD: stable metabolic disease; PMR: partial metabolic response; PMD: progressive metabolic disease; PFS progression free survival.